Leaflet NAPHCON-A ophthalmic drops solution

Indicated for: allergic conjunctivitis; ocular irritation

Route of administration: ophthalmic

Substance: naphazoline + pheniramine maleate (alpha-adrenergic decongestant and H1 antihistamine)

ATC: S01GA51 (Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants)

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Vision disturbances

This medicine may cause vision disturbances.

General data about NAPHCON-A

Substance: naphazoline + pheniramine maleate
Date of last drug list: 01-07-2013
Commercial code: W02243001
Pharmaceutical form: ophthalmic drops solution
Quantity: 1
Product type: original
Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.